Observational studyBreast cancer (Tokyo, Japan)2026
BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B).
Hitomi Sakai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.